REFERENCES

  • Atherton DJ, Proksch E, Schauber J, Stalder JF. Irritant diaper dermatitis: best practice management. SelfCare. 2015; 6(S1):1–11.
  • Ebner F, Heller A. at all. Topical use of dexpanthenol in skin disorders. American journal of clinical dermatology 2002;3(6):427-33.
  • Heise R, Skazik C, Marquardt Y, et al. Dexpanthenol modulates gene expression in skin wound healing in vivo. Skin Pharmacology and 2012;25:241–8.
  • Lacroix B, Didier E, Grenier JF. Effects of pantothenic acid on fibroblastic cell cultures. Research in Experimental Medicine. 1988;188:391–6.
  • Proksch E, de Bony R, Trapp S, Boudon S. Topical use of dexpanthenol: a 70th anniversary article. The Journal of dermatological treatment. 2017 Dec;28(8):766-773
  • Proksch E, Nissen HP. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. The Journal of dermatological treatment. 2002;13:173–8.
  • Wiederholt T, Heise R, Skazik C, et al. Calcium pantothenate modulates gene expression in proliferating human dermal Experimental Dermatology. 2009;18:969–78.
  • RECREOL® 50mg/g ointment summary of product characteristics.
  • RECREOL® 50mg/g cream summary of product characteristics.